Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

BACKGROUND: Bixalomer (BXL) was developed to improve gastrointestinal symptoms and reduce constipation, relative to sevelamer hydrochloride, in hemodialysis patients. We prospectively evaluated the safety and effectiveness of switching maintenance dialysis patients from sevelamer hydrochloride to BX...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hatakeyama, Shingo, Murasawa, Hiromi, Narita, Takuma, Oikawa, Masaaki, Fujita, Naoki, Iwamura, Hiromichi, Mikami, Joutaro, Kojima, Yuta, Sato, Tendo, Fukushi, Ken, Ishibashi, Yusuke, Hashimoto, Yasuhiro, Koie, Takuya, Saitoh, Hisao, Funyu, Tomihisa, Ohyama, Chikara
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852730/
https://ncbi.nlm.nih.gov/pubmed/24119202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-14-222
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi